par Blomme, B;Francque, Sven;Trepo, Eric 
;Libbrecht, Louis;Vanderschaeghe, Dieter;Verrijken, An;Pattyn, Piet;Van Nieuwenhove, Yves;Van de Putte, D.;Geerts, A;Colle, Isabelle;Delanghe, Joris;Moreno, Christophe ;Van Gaal, Luc;Callewaert, N.;Van Vlierberghe, Hans
Référence Digestive and Liver Disease, 44, 4, page (315-322)
Publication Publié, 2012-04
;Libbrecht, Louis;Vanderschaeghe, Dieter;Verrijken, An;Pattyn, Piet;Van Nieuwenhove, Yves;Van de Putte, D.;Geerts, A;Colle, Isabelle;Delanghe, Joris;Moreno, Christophe ;Van Gaal, Luc;Callewaert, N.;Van Vlierberghe, HansRéférence Digestive and Liver Disease, 44, 4, page (315-322)
Publication Publié, 2012-04
Article révisé par les pairs
| Résumé : | Non-alcoholic fatty liver disease is a spectrum of disorders ranging from steatosis to non-alcoholic steatohepatitis (NASH). Steatosis of the liver is benign, whereas NASH can progress to cirrhosis or even hepatocellular carcinoma. Currently, a liver biopsy is the only validated method to distinct NASH from steatosis. |
